InSight

Updates to the Home experience elevate entertainment and bring more convenience

Retrieved on: 
Montag, Juni 10, 2024
Technology, Retail, Audio, Video, Entertainment, Online, Utilities, Apps, Applications, Home Goods, Energy, Film & Motion Pictures, Software, TV and Radio, Hardware, Consumer Electronics, Atmos, Apple TV, Multimedia, FaceTime, MacOS, Siri, Mac (computer), Home, Apple Watch, Apple Pay, HomePod, AirPods, ICloud, Electricity, History, Name, Language, IPad, AirPlay, Animation, David Acord, Apple Developer, Apple Music, QR, IPhone, Machine learning, Music, Dolby Atmos, The Electric Company, Mac, App Store (iOS/iPadOS), InSight, Partnership, Apple Inc., TvOS, HDMI, IPadOS, PlayStation 4, IOS, Mobile phone

Apple® today announced software updates across its Home products that supercharge entertainment and deliver greater everyday convenience.

Key Points: 
  • Apple® today announced software updates across its Home products that supercharge entertainment and deliver greater everyday convenience.
  • tvOS 18 and iOS 18 are available as developer betas today, and will be available as free software updates this fall.
  • View the full release here: https://www.businesswire.com/news/home/20240610908437/en/
    tvOS 18 introduces intelligent new features like InSight that level up cinematic experiences.
  • New updates to FaceTime with Continuity Camera come with tvOS 18, making it more accessible than ever.

Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises

Retrieved on: 
Mittwoch, Mai 22, 2024
Security (finance), InSight, CFO, Exercise, Familial adenomatous polyposis, Sale, Ladenburg Thalmann, ADS, Treasury, Acquisition, FAP, Series

The ADSs issuable upon exercise of the Existing Warrants are registered pursuant to a registration statement (File No.

Key Points: 
  • The ADSs issuable upon exercise of the Existing Warrants are registered pursuant to a registration statement (File No.
  • Certain existing warrant holders exercised warrants without a replacement warrant.
  • The gross proceeds to the Company from the exercise of the previously issued warrants and Existing Warrants are expected to be approximately $7 million prior to deducting placement agent fees and estimated offering expenses.
  • Each of the Company’s American Depositary Shares comprises 400 Ordinary Shares and therefore the equivalent number of ADSs in issue is 10,319,038.

Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting

Retrieved on: 
Dienstag, Mai 21, 2024
Patient, InSight, PD, Cohort, Cancer prevention, Medication, Safety, Adenoma, Principal investigator, MD, Acquisition, Research institute, Duodenum, PR, Gastrointestinal disease, Pharmaceutical industry

The study was partially supported by $20M in grant funding from the Cancer Prevention and Research Institute of Texas under product development awards DP22053 and DP190069.

Key Points: 
  • The study was partially supported by $20M in grant funding from the Cancer Prevention and Research Institute of Texas under product development awards DP22053 and DP190069.
  • Polyp outcomes were classified into Progressive Disease (PD: >20% increase in polyp burden), Stable Disease (SD: ± 20% change in polyp burden) or Partial Response (PR: >20% reduction in polyp burden).
  • In the duodenum, 14/18 (78%) patients were non-progressors with 11/18 (61%) of these patients with PR.
  • Polyp burden data at 12 months compared with baseline will be presented at the InSIGHT scientific conference in Barcelona on June 19-22, 2024.

SEC Charges Five Investment Advisers for Marketing Rule Violations

Retrieved on: 
Freitag, April 12, 2024
InSight, Investment management, Monex, Marketing, Commission, Division, Financial adviser

Bradesco, Credicorp, InSight, and Monex received reduced penalties because of the corrective steps they undertook in advance of being contacted by the SEC staff.

Key Points: 
  • Bradesco, Credicorp, InSight, and Monex received reduced penalties because of the corrective steps they undertook in advance of being contacted by the SEC staff.
  • “The Marketing Rule’s provisions are crucial to protecting investors from misleading advertising claims,” said Corey Schuster, Co-Chief of the SEC Enforcement Division’s Asset Management Unit.
  • “Today’s actions show that we will continue to employ targeted initiatives to ensure that investment advisers fully comply with their obligations under the rule.
  • This is the second set of cases that the Commission has brought as part of an ongoing targeted sweep concerning Marketing Rule violations after charging nine advisory firms in September 2023.

Adjust Unveils Mobile Analytics Solution Powered by AI, Advanced Machine Learning to Uncover Incrementality

Retrieved on: 
Mittwoch, April 17, 2024
Marketing, Increment, InSight, ROI, Machine learning, SAN, Pret, IOS, Pret a Manger, Telescopic sight

SAN FRANCISCO, April 17, 2024 /PRNewswire/ -- Today, leading measurement and analytics company Adjust unveiled InSight, a machine learning and AI-powered measurement solution giving marketers a data-driven lens to evaluate campaign effectiveness. With the introduction of Adjust's InSight, marketers can now benefit from incrementality analysis to measure the impact that particular marketing actions, such as budget increases, have on ROI. This enables marketers to easily analyze these marketing activities against target KPIs – discerning if they provide incremental lift, cannibalize organics or have no effect – to make ROI positive decisions.

Key Points: 
  • With InSight – Adjust's first recommendation-driven solution – marketers can leverage:
    Synthetic control groups that eliminate data variables and leave the heavy lifting to Adjust.
  • Adjust's powerful incrementality solution has been in the early access phase, carefully tested and refined with the help of existing customers.
  • "With their machine learning models doing the heavy lifting and analyzing our historical aggregated data, insightful outcomes and advanced incrementality metrics are available at the push of a button."
  • To learn more about incrementality analysis and how to take the guesswork out of marketing measurement, download The mobile marketer's essential guide to Incrementality Analysis .

Arcadis Secures Key Contracts with Nevada Department of Transportation for Mobility and Digital Solutions

Retrieved on: 
Dienstag, Februar 13, 2024
ERP, Engineering, ERS, Weather, Travel, InSight, Innovation system, Transport, Interactive voice response, Intelligence, Arcadis, Information, Congestion, Safety, IVR, HRIS, ATMS, CRM, Automation, GIS, NDOT, Waze, Partnership

Deployment of Arcadis' inSIGHT ATMS transportation management and Travel-IQ traveler information systems to provide real-time situational awareness of traffic conditions state-wide.

Key Points: 
  • Deployment of Arcadis' inSIGHT ATMS transportation management and Travel-IQ traveler information systems to provide real-time situational awareness of traffic conditions state-wide.
  • Arcadis' scope of work for NDOT includes helping to modernize the statewide freeway management software by replacing the legacy Advanced Transportation Management System (ATMS) application with the inSIGHT ATMS software solution.
  • Kevin Bebenek, Global President of Intelligence Business Area at Arcadis, said: "Arcadis shares NDOT's commitment to meaningful technical innovation.
  • With much disruptive technology emerging in transportation, Arcadis' global capabilities in both future-proofing mobility operations and digital solutions position it well to deliver safe, sustainable, equitable transportation systems.

Intelerad’s InSight PACS Awarded Best in KLAS for UK and Ireland PACS

Retrieved on: 
Mittwoch, Februar 7, 2024
Partnership, Radiology, Consultant, AI, Feedback, Teleradiology, Research, MDT, Patient, InSight, Algorithm, Health, Trust, PACS, Human

The company has earned its recognition as the 2024 Best in KLAS vendor for the UK and Ireland PACS, leading the category across both regions based on provider and payers’ feedback in 2023.

Key Points: 
  • The company has earned its recognition as the 2024 Best in KLAS vendor for the UK and Ireland PACS, leading the category across both regions based on provider and payers’ feedback in 2023.
  • Intelerad’s InSight PACS is a tailor-made PACS solution that has been adopted by over 250 healthcare providers across the UK and Ireland.
  • A Best in KLAS award determines the standard of excellence that the top vendors should provide in a partnership.
  • The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation.

New National Report Defines Inequities and Unmet Needs for At-Risk AANHPI Communities

Retrieved on: 
Dienstag, Januar 23, 2024
Risk, Mindfulness, Native Hawaiians, Korean Americans, Mental health, Ageing, Public, Relative key, Chinese American Service League, Organization, InSight, Annual report, Poverty, AANHPI, CASL, Education

CHICAGO, Jan. 23, 2024 /PRNewswire-PRWeb/ -- Change InSight, a first-of-its-kind data platform built to quantify historical challenges facing at-risk communities and identify solutions, today released its second annual report outlining risk factors for the clients of 19 social service organizations across the country. The findings were uncovered and defined through surveying nearly 6,000 in-need individuals representing 30 often-overlooked Asian American, Native Hawaiian, and Pacific Islander (AANHPI) communities.

Key Points: 
  • Second annual Change InSight report outlines barriers to equity for AANHPI communities across the country.
  • The findings were uncovered and defined through surveying nearly 6,000 in-need individuals representing 30 often-overlooked Asian American, Native Hawaiian, and Pacific Islander (AANHPI) communities.
  • "Change InSight continues to illuminate the unique challenges faced by the diverse, multi-ethnic Americans in the AANHPI community," said U.S. Sen. Tammy Duckworth.
  • I applaud Change Insight's commitment to understanding individual communities and I'll keep working on the federal level to bring awareness and support to AANHPI communities."

SBOM Automation Platform Vigilant Ops Secures $2 Million in Seed Funding from DataTribe

Retrieved on: 
Donnerstag, Januar 4, 2024
Technology, Finance, Security, Professional Services, Software, Start-Up, Networks, Internet, Data Management, ODNI, VEX, Federal Energy Regulatory Commission, SBOM, InSight, Director of National Intelligence, FDA, United States Intelligence Community, FERC, National Security Strategy, NSA, Legislation, CISA, Bill of materials, SPDX, Federation, Food and Drug Administration, Organization, Automation, National Security Agency, Information technology, Data science, Medical device

Vigilant Ops, winner of the 6th annual DataTribe Challenge in November, performs continuous vulnerability monitoring and alerting, security patch notifications, and the ability to upload SBOMs -- lists of the software libraries embedded in products -- from alternate sources.

Key Points: 
  • DataTribe , a global cyber foundry that invests in and co-builds next-generation cybersecurity and data science companies, today announced a $2 million seed investment in Vigilant Ops , a leading automation platform for the generation, maintenance, and authenticated sharing of certified Software Bill of Materials (SBOM).
  • Vigilant Ops will use the funding to expand the capabilities of its InSight platform across multiple critical infrastructure industries.
  • Leo Scott, DataTribe CTO, will join the Vigilant Ops Board.
  • The most recent release of the InSight Platform now includes automated import of various SBOM formats, supporting industry standards like CycloneDX and SPDX.

VBI Vaccines Reports Third Quarter 2023 Financial Results

Retrieved on: 
Dienstag, November 14, 2023
Biotechnology, FDA, Other Health, Health, Pharmaceutical, Oncology, Research, Infectious Diseases, Science, COVID-19, Clinical Trials, Shekel, MLE, High-net-worth individual, Hepatitis B vaccine, GMT, HBsAg, Net, AASLD, Bank statement, Disease, GBM, Government, Administration, Patient, HBV, Research and development, Prison, Allergy, Fast track (FDA), Autoimmune disease, InSight, Liver, VBI, Messenger, Internationalized domain name, GAAP, Vaccine, Cancer, Partnership, R, Seroconversion, Growth, Infection, Israeli new shekel, Pharmaceutical industry, Video game, Rare-earth element, Cryptocurrency, Bank

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.
  • Cost of Revenues: Cost of revenues was $2.5 million in the third quarter of 2023 as compared to $2.7 million in the third quarter of 2022.
  • Research and Development (R&D): R&D expenses for the third quarter of 2023 were $1.5 million as compared to $5.0 million for the third quarter of 2022.
  • Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results.